Cost of Bharat Biotech’s nasal vaccine revealed; Check details The needle-less vaccine can be administered as a precautionary dose to adults who have been vaccinated with two doses of… December 27, 2022 13:08 IST
Bharat Biotech’s intranasal COVID-19 vaccine gets approved; To be available as booster dose soon According to Bharat Biotech, the intranasal vaccine has several advantages because the nasal route has excellent potential for vaccination due… December 23, 2022 11:46 IST
DCGI approves Bharat Biotech’s intranasal COVID booster dose for restricted use The pharma company in its earlier statement said iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized… November 25, 2022 19:13 IST
50 mn doses of Covaxin set to expire early 2023 due to poor demand Due to lack of product demand, production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech earlier… November 6, 2022 12:40 IST
AstraZeneca’s nasal COVID-19 vaccine fails clinical trial Last month, India’s Health Ministry approved Bharat Biotech’s COVID-19 nasal spray vaccine while China’s CanSino Biologics Inc last month won… October 11, 2022 15:46 IST
Bharat Biotech applies for market authorisation from DCGI for its intranasal COVID-19 vaccine According to the company, the intranasal vaccine is a heterologous booster dose. Moreover, the vaccine development data will be submitted… September 12, 2022 14:43 IST
Bharat Biotech’s intranasal COVID-19 vaccine gets DCGI approval for restricted use This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, a press release from… September 6, 2022 20:19 IST
Clinical data disclosure critical for Bharat Biotech COVID-19 intranasal vaccine success in India: GlobalData Even though intranasal vaccines can produce both local and systemic immunity, there can be challenges around long-lasting immunity, the company… August 25, 2022 14:07 IST
Nigeria introduces Bharat Biotech’s ROTAVAC vaccine for immunisation in children At present, Nigeria accounts for 14 percent of all childhood rotavirus deaths globally, making it the country with the second-highest… August 24, 2022 13:57 IST
Bharat Biotech concludes clinical trials of intranasal COVID-19 vaccine; Says it is safe and immunogenic The vaccine maker claims that BBV154 has the double benefit of enabling faster development of variant-specific vaccines and easy nasal… August 15, 2022 14:41 IST
Bharat Biotech expects DGCI’s nod for intranasal COVID-19 vaccine this month Ella said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no single… August 2, 2022 13:40 IST
ExcellGene partners with Bharat Biotech, CEPI and Sydney University to develop ‘variant-proof’ COVID-19 vaccine On Tuesday, ExcellGene informed that it will produce complex chimeric Spike antigens using its engineered CHOExpress-cell-based technology. July 26, 2022 19:24 IST
Germany to recognise Covaxin for travel from June 1 German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start… Updated: May 26, 2022 14:49 IST
CEPI to provide up to $19.3 m to Bharat Biotech, others for development of ‘variant-proof’ Covid vaccine CEPI will provide funding of up to $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to… May 11, 2022 08:09 IST
Bharat Biotech must address WHO’s Covaxin suspension to avoid EUL cancellation, says MEA In a communication to Dr V K Paul, the convenor of a key empowered group on Covid vaccination, on Tuesday… April 28, 2022 19:56 IST
Emami on look out for more good acquisitions, strategic investment opportunities in startups ecosystem
9 Photos Indian Railways begins mega restoration work after horrific Balasore disaster – See Pics 17 hours agoJune 4, 2023
11 Photos 3 trains, a head-on collision and tragedy on tracks: India’s deadliest train accident | IN PICS 2 days agoJune 3, 2023
10 Photos Rainfall, gusty winds bring much-needed respite for Northern India | See Photos 4 days agoJune 1, 2023
